A5026418528- Prostate Cancer Diagnosis and Treatment
- Advanced Radiotherapy Techniques
- Prostate Cancer Treatment and Research
- Cancer survivorship and care
- Advances in Oncology and Radiotherapy
- Gastrointestinal Tumor Research and Treatment
- Lung Cancer Diagnosis and Treatment
- Bladder and Urothelial Cancer Treatments
- Sarcoma Diagnosis and Treatment
- Management of metastatic bone disease
- Chronic Myeloid Leukemia Treatments
- Sports Performance and Training
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Urological Disorders and Treatments
- Head and Neck Cancer Studies
- Muscle metabolism and nutrition
- Regional Development and Environment
- Exercise and Physiological Responses
- Effects of Radiation Exposure
- Endometrial and Cervical Cancer Treatments
- Soft tissue tumor case studies
Collaborative Group (United States)
2023
Start Treatment & Recovery Centers
2023
Azienda Ospedaliero Universitaria Maggiore della Carita
2015-2022
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
2015-2022
Candiolo Cancer Institute
2006-2021
Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
2017
Vita-Salute San Raffaele University
2017
Istituti di Ricovero e Cura a Carattere Scientifico
2017
The present study aims to identify predictive factors for urinary toxicity and self-reported symptoms after external beam radiotherapy (EBRT) prostate cancer.Two-hundred eighty patients treated with EBRT cancer were included in the study. Toxicity was scored following grading system based on Radiation Therapy Oncology Group (RTOG) scale. International Prostatic Symptom Score (IPSS) Consultation Incontinence Questionnaires - Short Form (ICIQ-SF) used analyse symptoms. Acute late toxicities...
To evaluate the outcome of patients treated with salvage radiotherapy after radical prostatectomy and to investigate effects independent predictors on survival.From January 2000 December 2015, 234 biochemical/clinical recurrences were submitted (SRT). One hundred fifty-seven (67%) received three-dimensional (3D) conformal while 77 (33%) intensity-modulated (IMRT) or IMRT/image-guided by tomotherapy. The median RT dose prostate bed was 70.2 Gy (range: 66-79 Gy). investigated endpoints...
9509 Background: MSC-pain, muscle cramps, myalgias, arthralgias-are commonly associated with imatinib therapy, affecting 25% to 50% of patients. The cause is still unknown. MSC usually mild moderate and manageable without reduction dose. Calcium magnesium supplements have occasionally provided some relief. It rather difficult quantify patients who deserve interruption or analgesia on the base symptoms alone. Since CK values are elevated during we evaluate as a surrogate marker MSC. Methods:...
Purpose or ObjectiveArtificial neural networks (ANNs) were used in the last years for development of models prediction radiation-induced toxicity following RT.In fact, ANNs are powerful tools pattern classification light their ability to model extremely complex functions and huge numbers data.However, major counterpoint is that some specific cases they might not deliver realistic results due missing critical capacity.The objective this study was develop a method assessing reliability...
9546 Background: In GIST MOA are rare events (8–10%) with a prognostic and predictive impact (JCO 2005;23:5795). To stage GIST, NCCN recommends either CT or abdominal MRI + chest imaging, suggesting PET scan only if early response assessment is needed. Therefore, may be missed by standard work up. We evaluated TB (largest tumor diameter > 12 centimetres) at diagnosis was associated to higher incidence of MOA. Methods: From 01/02 12/05, 66 pts affected were treated followed-up our...